Just How Positive is Piper Jaffray on Henry Schein Inc (NDAQ:HSIC) Following Their Upgrade?

September 17, 2017 - By Migdalia James

  Just How Positive is Piper Jaffray on Henry Schein Inc (NDAQ:HSIC) Following Their Upgrade?

Investors sentiment decreased to 0.81 in 2016 Q4. Its down 0.19, from 1 in 2016Q3. It dropped, as 50 investors sold Henry Schein, Inc. shares while 192 reduced holdings. 70 funds opened positions while 127 raised stakes. 71.97 million shares or 0.99% more from 71.27 million shares in 2016Q3 were reported.

Profund Advsrs Limited Liability Company reported 6,934 shares. Da Davidson holds 0% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 1,217 shares. Whittier Com Of Nevada reported 185 shares stake. Kings Point Capital holds 0.01% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 200 shares. The California-based Montecito Bankshares Tru has invested 0.07% in Henry Schein, Inc. (NASDAQ:HSIC). New York State Teachers Retirement System stated it has 0.06% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Wealthtrust Fairport Ltd Llc has invested 0.03% in Henry Schein, Inc. (NASDAQ:HSIC). Texas Permanent School Fund invested 0.05% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Magnetar Limited Liability Corp invested in 6,606 shares. 241,531 are held by Davis R M. Putnam Invs Limited Liability Com accumulated 11,580 shares. Anderson Hoagland & Com has 0.48% invested in Henry Schein, Inc. (NASDAQ:HSIC). Invesco Limited reported 964,532 shares. Daiwa holds 0% or 2,150 shares in its portfolio. First Manhattan invested in 545 shares.

Since March 17, 2017, it had 0 insider purchases, and 3 selling transactions for $5.09 million activity. $1.71 million worth of stock was sold by RACIOPPI MICHAEL on Monday, March 20. 12,578 shares valued at $2.20 million were sold by BENJAMIN GERALD A on Thursday, May 11. The insider MLOTEK MARK E sold 5,559 shares worth $950,478. $1.60 million worth of Henry Schein, Inc. (NASDAQ:HSIC) was sold by McGlynn Lorelei. Minowitz Robert also sold $1.29M worth of Henry Schein, Inc. (NASDAQ:HSIC) on Friday, May 12.

Henry Schein Inc (NDAQ:HSIC) Stock Upgrade

The rating for shares of Henry Schein Inc (NDAQ:HSIC) were upgraded by analysts at Piper Jaffray from a “Neutral” rating to a “Overweight” rating in a note released on 15 September.

Investors sentiment decreased to 0.81 in 2016 Q4. Its down 0.19, from 1 in 2016Q3. It dropped, as 50 investors sold Henry Schein, Inc. shares while 192 reduced holdings. 70 funds opened positions while 127 raised stakes. 71.97 million shares or 0.99% more from 71.27 million shares in 2016Q3 were reported.

Profund Advsrs Limited Liability Company reported 6,934 shares. Da Davidson holds 0% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 1,217 shares. Whittier Com Of Nevada reported 185 shares stake. Kings Point Capital holds 0.01% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 200 shares. The California-based Montecito Bankshares Tru has invested 0.07% in Henry Schein, Inc. (NASDAQ:HSIC). New York State Teachers Retirement System stated it has 0.06% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Wealthtrust Fairport Ltd Llc has invested 0.03% in Henry Schein, Inc. (NASDAQ:HSIC). Texas Permanent School Fund invested 0.05% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Magnetar Limited Liability Corp invested in 6,606 shares. 241,531 are held by Davis R M. Putnam Invs Limited Liability Com accumulated 11,580 shares. Anderson Hoagland & Com has 0.48% invested in Henry Schein, Inc. (NASDAQ:HSIC). Invesco Limited reported 964,532 shares. Daiwa holds 0% or 2,150 shares in its portfolio. First Manhattan invested in 545 shares.

Since March 17, 2017, it had 0 insider purchases, and 3 selling transactions for $5.09 million activity. $1.71 million worth of stock was sold by RACIOPPI MICHAEL on Monday, March 20. 12,578 shares valued at $2.20 million were sold by BENJAMIN GERALD A on Thursday, May 11. The insider MLOTEK MARK E sold 5,559 shares worth $950,478. $1.60 million worth of Henry Schein, Inc. (NASDAQ:HSIC) was sold by McGlynn Lorelei. Minowitz Robert also sold $1.29M worth of Henry Schein, Inc. (NASDAQ:HSIC) on Friday, May 12.

Henry Schein, Inc. (NASDAQ:HSIC) Ratings Coverage

Among 4 analysts covering Henry Schein Inc. (NDAQ:HSIC), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Henry Schein Inc. has $218 highest and $178 lowest target. $198’s average target is 138.90% above currents $82.88 stock price. Henry Schein Inc. had 4 analyst reports since April 12, 2017 according to SRatingsIntel. Barrington Research maintained Henry Schein, Inc. (NASDAQ:HSIC) on Wednesday, May 10 with “Outperform” rating. The company was upgraded on Monday, August 7 by Northcoast. As per Wednesday, April 12, the company rating was maintained by Craig Hallum. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, May 10 report.

The stock increased 2.86% or $2.31 on September 15, reaching $82.88. About 2.92M shares traded or 104.20% up from the average. Henry Schein, Inc. (NDAQ:HSIC) has risen 4.05% since September 17, 2016 and is uptrending. It has underperformed by 12.65% the S&P500.

Investors wait Henry Schein, Inc. (NASDAQ:HSIC) to report on November, 1. its quarterly earnings Wall Street analysts expect $1.79 EPS, up $0.11 or 6.55 % from last year’s $1.68 same quarter earnings. This translates into $282.93M profit for HSIC giving the stock a 11.58 P/E. This is assuming the current $1.79 EPS is accurate. Henry Schein, Inc.’s Wall Street analysts see 2.29 % EPS growth, taking into account the $1.75 EPS reproted in the previous quarter,

Henry Schein, Inc. is a provider of healthcare services and products primarily to office dental, animal health and medical practitioners. The company has market cap of $13.10 billion. The Firm operates through two divisions: healthcare distribution, and technology and value-added services. It has a 24.25 P/E ratio. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: Benzinga.com which released: “Looking For Amazon-Proof Stocks? Try Henry Schein” on September 15, 2017, also Prnewswire.com with their article: “Henry Schein Partners With IMF And LUGPA To Raise Awareness Of The Critical …” published on August 31, 2017, Prnewswire.com published: “Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By …” on August 25, 2017. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC) were released by: Prnewswire.com and their article: “Henry Schein MicroMD EMR┬« Earns ONC-Health IT Certification From Drummond …” published on September 08, 2017 as well as Nasdaq.com‘s news article titled: “Henry Schein’s Merritt Buyout to Boost US Veterinary Arm” with publication date: August 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.